Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,395 | 94,895 | N/A | N/A | N/A |
| Receivables | 127 | 1,474 | N/A | N/A | N/A |
| Other current assets | 3,163 | 2,862 | 12 | 8 | 0 |
| TOTAL | $58,501 | $101,197 | $879 | $1,259 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6,865 | 11,613 | 6,497 | 4,131 | N/A |
| Other Non-Current Assets | 50,012 | 73,668 | 25 | 80 | 0 |
| TOTAL | $56,877 | $85,281 | $6,522 | $4,211 | $N/A |
| Total Assets | $115,378 | $186,478 | $7,401 | $5,470 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,435 | 3,311 | 2,781 | 1,802 | 0 |
| Accrued Expenses | 8,715 | 11,518 | 15,065 | 12,235 | N/A |
| TOTAL | $16,952 | $18,249 | $17,846 | $14,037 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 38,933 | 70,500 | 0 | 0 | 0 |
| TOTAL | $38,933 | $70,500 | $N/A | $N/A | $N/A |
| Total Liabilities | $55,885 | $88,749 | $17,846 | $14,037 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,703 | 1,388 | N/A | N/A | N/A |
| Retained earnings | -163,429 | -85,627 | N/A | N/A | N/A |
| Other shareholders' equity | -27 | -20 | -10,445 | -8,567 | 0 |
| TOTAL | $59,493 | $97,729 | $-10,445 | $-8,567 | $N/A |
| Total Liabilities And Equity | $115,378 | $186,478 | $7,401 | $5,470 | $0 |